Medicare Part D Protected-Class Policy Is Associated With Lower Drug Rebates
Health Affairs · 2024
DOI: 10.1377/hlthaff.2024.00273 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health Affairs, 2024. Verfasst von Pragya Kakani und 3 weiteren Autor:innen. Beteiligte Einrichtung: Pragya Kakani (pka4006@med.cornell.edu), Cornell University, New York, New York. Hauptthemen laut MEDLINE: Medicare Part D. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIA NIH HHS.
Abstract (Originalsprache)
Medicare Part D does not allow plans to exclude drugs in six protected classes from their formularies, which may limit plans' ability to negotiate rebates and lead to higher spending. We estimated the association between protected-class status, US-level estimated rebates, and formulary coverage during the period 2011-19. We found that protected classes indeed had significantly lower exclusion rates in Medicare Part D during this period relative to nonprotected classes, and this difference was larger than the corresponding difference in commercial plans. US-level average rebates grew 22.5 percentage points less in protected than in nonprotected classes during 2011-19, a period when formulary exclusions increased. Relative to nonprotected classes, US-level average rebates in protected classes were especially low among drugs with high Medicare market share. These results suggest that Medicare Part D protected-class policy may reduce rebates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Pragya Kakani (pka4006@med.cornell.edu), Cornell University, New York, New York.
- Michael Anne Kyle, University of Pennsylvania, Philadelphia, Pennsylvania.
- Amitabh Chandra, Harvard University, Boston, Massachusetts.
- Luca Maini, Harvard University.
Förderung
- NCI NIH HHS
- NIA NIH HHS
Zitieren
APA
Kakani, P., Kyle, M. A., Chandra, A., & Maini, L. (2024). Medicare Part D Protected-Class Policy Is Associated With Lower Drug Rebates. Health Affairs. https://doi.org/10.1377/hlthaff.2024.00273
Vancouver
Kakani P, Kyle MA, Chandra A, Maini L. Medicare Part D Protected-Class Policy Is Associated With Lower Drug Rebates. Health Affairs. 2024. doi:10.1377/hlthaff.2024.00273
BibTeX
@article{Kakani2024,
author = {Kakani, Pragya and Kyle, Michael Anne and Chandra, Amitabh and Maini, Luca},
title = {Medicare Part D Protected-Class Policy Is Associated With Lower Drug Rebates},
journal = {Health Affairs},
year = {2024},
doi = {10.1377/hlthaff.2024.00273}
}
EUVIMED